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Abstract
Background: Hemorrhagic fever with renal syndrome (HFRS) caused by hantavirus infection is characterized by fever,
renal dysfunction and hemorrhage. An animal model mimicking symptoms of HFRS remains to be established. In this
study, we evaluated the pathogenicity of an HFRS patient-derived Hantaan virus (HTNV) in adult mice.
Methods: Five clones of HTNV strain KHF 83-61 BL (KHFV) that was derived from blood of an HFRS patient were
obtained by plaque cloning. The pathogenicity of the virus clones was evaluated by using 6-week-old female BALB/c
mice. Sequence analysis of the viral genome was performed by conventional methods.
Results: All of the mice intravenously inoculated with KHFV clone (cl)-1, -2, -3 and -5 showed signs of disease such as
transient body weight loss, ruffled fur, reduced activity and remarkably prominent hemorrhage in the renal medulla at
6 to 9 days post-inoculation (dpi) and then recovered. In contrast, mice intravenously inoculated with KHFV cl-4 did not
show any signs of disease. We selected KHFV cl-5 and cl-4 as representative of high-pathogenic and low-
pathogenic clones, respectively. Quantities of viral RNA in kidneys of KHFV cl-5-infected mice were larger than
those in KHFV cl-4-infected mice at any time point examined (3, 6, 9 and 12 dpi). The quantities of viral RNA
of KHFV cl-5 and cl-4 peaked at 3 dpi, which was before the onset of disease. Sequence analysis revealed that the amino
acid at position 417 in the glycoprotein Gn was the sole difference in viral proteins between KHFV cl-5 and cl-4. The result
suggests that amino acid at position 417 in Gn is related to the difference in pathogenicity between KHFV cl-5 and cl-4.
When the inoculum of KHFV cl-5 was pretreated with a neutralizing antibody against HTNV strain 76-118, which belongs
to the same serotype as KHFV clones, mice did not show any signs of disease, confirming that the disease was caused by
KHFV infection.
Conclusion: We found that an HFRS patient-derived HTNV caused renal hemorrhage in adult mice. We anticipate that
this infection model will be a valuable tool for understanding the pathogenesis of HFRS.
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Background
Hantaviruses belonging to the family Bunyaviridae,
genus Hantavirus cause two types of disease in humans:
hemorrhagic fever with renal syndrome (HFRS) and
hantavirus pulmonary syndrome (HPS). HFRS is caused
by old world hantaviruses such as Hantaan virus
(HTNV), Seoul virus, Dobrava-Belgrade virus and
Puumala virus (PUUV) and is characterized by renal
dysfunction and hemorrhage. HPS is caused by new
world hantaviruses such as Andes virus (ANDV) and Sin
Nombre virus (SNV) and is characterized by acute
respiratory failure. Although the major symptoms and
target organs are different, immune responses and
impairment of vascular function are thought to be in-
volved in the pathogenesis of HFRS and HPS [1].
Hantavirus is a spherical enveloped virus with a tri-
segmented single-strand negative-sense RNA genome.
The segments designated as small (S), medium (M) and
large (L) segments encode nucleocapsid protein (N),
glycoprotein (GP) and RNA-dependent RNA polymerase
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(RdRp), respectively. GP is co-translationally cleaved into
Gn and Gc.
An animal model is necessary for elucidation of the
mechanism of pathogenesis and for development of a
vaccine and therapeutic measures. Therefore, many re-
searchers have tried to develop animal models of HPS
and HFRS. For HPS, a hamster model using ANDV has
been successfully developed [2]. Recently, a non-human
primate model using SNV passaged in a deer mouse has
also been reported [3]. These models showed acute re-
spiratory distress and severe pulmonary edema, which
closely resemble HPS in humans. As for an animal
model of HFRS, a non-human primate model using
PUUV passaged in voles has been reported, although the
animal showed only mild proteinuria, cell filtration and
tubular damage in the kidneys, similar to a mild case of
HFRS [4]. Various attempts to develop a mouse model
of HFRS have also been made. Hantaviruses generally
cause asymptomatic infection in adult mice. On the
other hand, infection of suckling and newborn mice with
hantaviruses causes lethal neurological disease or persist-
ent infection [5, 6], which are different from the disease
in humans. We have also tried to develop a mouse
model of HFRS. We showed that infection of severe
combined immunodeficient mice with HTNV caused
lethal wasting disease with pulmonary edema [7, 8]. In
addition, we showed that depletion of neutrophils inhib-
ited the development of pulmonary edema. However,
there was no hemorrhagic lesion that is characteristic of
HFRS [8]. Thus, to date, there has been no animal
model showing severe symptoms of HFRS.
As described above, hantaviruses generally cause
asymptomatic infection in adult mice. However, lethal
adult mice models of HFRS were exceptionally reported
by two groups. Wichmann et al. [9] reported that HTNV
strain 76-118 caused lethal neurological disease in adult
mice. However, the disease was different from HFRS.
Asada et al. [10] reported that HTNV strain KHF 83-61
BL (KHFV), which was derived from blood of an HFRS
patient, caused lethal infection in adult mice after intra-
venous inoculation. Although the authors described that
the mice showed ruffled fur and hypoactivity, details of
the disease remain unclear. In this study, we tried to
characterize the pathogenicity of KHFV in mice by using
five clones of KHFV and surprisingly found that some
clones of KHFV caused renal hemorrhage in adult mice
as in HFRS patients.
Methods
Viruses and cells
The HTNV strain KHFV was isolated from blood of a
patient with Korean hemorrhagic fever by Dr. H. W. Lee
and passaged 10 times in the brains of newborn ICR
mice [10]. Five clones of KHFV (KHFV cl-1 to -5) were
cloned by plaque-purification on Vero E6 cells (ATCC
CRL-1586). A stock of KHFV clones was prepared in
Vero E6 cells and stored at −80 °C until use. The in-
fectivity titers (focus-forming units; FFU) of the stock
of KHFV clones were measured by counting infected
cell foci detected by immunostaining as described
previously [11].
Pathogenicity in mice
Female BALB/cAJcl mice (6 weeks old) were purchased
from CLEA Japan Inc. Mice inoculated with 105 FFU of
KHFV cl-1 to -5 via the intraperitoneal (i.p.) or intraven-
ous (i.v.) route were observed for 2 weeks and then
euthanized and subjected to autopsy. In another experi-
ment, kidneys of mice intravenously inoculated with 105
FFU of KHFV cl-4 and cl-5 were collected at 3, 6, 9 and
12 days post-inoculation (dpi) and subjected to quantifi-
cation of viral RNA and pathological examination. In
experiments for examination of dose dependency, serial
10-fold dilutions of KHFV cl-5 (102 to 105 FFU) were
intravenously inoculated into mice, and the mice were
observed for 2 weeks. In experiments for examination of
the specificity of virus in disease development, 105 FFU of
KHFV cl-5 were pretreated with 8-fold dilutions of sera of
HTNV strain 76-118-infected mice (neutralizing antibody
titer: 640) [6] or normal mice at 37 °C for 1 h and intra-
venously inoculated into mice.
Quantification of viral RNA
Total RNAs extracted from kidney homogenates of in-
fected mice were reverse-transcribed into cDNA by
using random primers and SuperScript II Reverse
Transcriptase (Thermo) according to the manufacturer’s
instructions. The cDNAs were subjected to real-time
PCR analysis using primers KHFV-SF (5′-TGGACCA
AAGGATTATTGTGC-3′) and HTNV-SR (5′-CATCC
CCTAAGTGGAAGTTGTC-3′), Universal Probe Library
#75, LightCycler 480 Probes Master and LightCycler 480
Instrument II (Roche) according to the manufacturer’s
instructions. The open reading frame (ORF) of the NP gene
of KHFV cl-5 was amplified by PCR using primers HTN-
NP1F-EcoRI (5′-AGAGAATTCATGGCAACTATGGAGG
AATTAC-3′) and HTN-NP429R-XhoI (5′-ATTCTCGA
GTTAGAGTTTCAAAGGCTCTTG-3′) and Platinum Taq
DNA Polymerase High Fidelity (Thermo) and then cloned
into the pGEM T vector (Promega) and used as a standard
in real-time PCR.
Nucleotide sequencing
Total RNAs extracted from Vero E6 cells infected with
KHFVs were reverse-transcribed into cDNA as described
above. The cDNAs covering the entire viral genome
were amplified by PCR using primers and Platinum Taq
DNA Polymerase High Fidelity (Thermo) according to
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the manufacturer’s instructions. We amplified cDNAs
including 3′ and 5′ terminal non-coding regions of each
segment by adding adaptor to the 3′ end of genomic
and anti-genomic RNAs as described in a previous study
[12]. Information on the primers is available on request.
The PCR products were purified with a MinElute PCR
Purification Kit or a MinElute Gel Extraction Kit
(Qiagen) and subjected to direct sequencing using a
BigDye Terminator v3.1 Cycle Sequencing Kit and Applied
Biosystems 3130xl Genetic Analyzer (Thermo) according
to the manufacturer’s instructions. Sequences were ana-
lyzed by Genetyx-Mac version 15.0.1 (Genetyx Corp.).
Statistical analysis
Student’s t test was used for comparison of quantities of
viral RNA. A P value <0.05 was considered statistically
significant.
Results
Pathogenicity of KHFV clones in mice
In order to examine the pathogenicity of KHFV cl-1 to
-5 in mice, 105 FFU each of the viruses were inoculated
into mice via the i.p. or i.v. route. The mice inoculated
with the viruses via the i.p. route did not develop any
signs of disease except for one of the three mice inocu-
lated with KHFV cl-5, which developed signs of disease
such as body weight loss, ruffled fur and decrease in
movement at 6 to 9 dpi and then recovered (Table 1). In
contrast, when the viruses were inoculated via the i.v.
route, although the mice inoculated with KHFV cl-4 did
not develop any signs of disease, all of the mice inocu-
lated with KHFV cl-1, -2, -3 and -5 developed signs of
disease at 6 to 9 dpi (Table 1). Relative changes in body
weight of mice inoculated with KHFV cl-1 to -5 via the
i.v. route are shown in Fig. 1. Body weight of the mice
inoculated with KHFV cl-4 gradually increased as did
that of mock-infected mice. In contrast, body weight of
the mice inoculated with KHFV cl-1, -2, -3 and -5
decreased by about 10% at around 6 to 9 dpi and then
increased. We selected KHFV cl-5 and cl-4 as
representative of high-pathogenic and low-pathogenic
clones, respectively.
Quantity of viral RNA in the kidney
To determine whether viral load in the kidney was
correlated with disease progression, the quantity of viral
RNA in kidneys of mice inoculated with 105 FFU of
KHFV cl-4 or cl-5 via the i.v. route was examined by
real-time PCR. The quantity of viral RNA of KHFV cl-5
was greatest at 3 dpi, which was before the onset of
disease, and gradually decreased (Fig. 2). Similar results
were obtained from analysis of KHFV cl-4-infected mice.
However, the copy numbers of viral RNA of KHFV cl-5
were larger than those of KHFV cl-4 at any time point.
In the process of sample collection, we found that
kidneys of mice inoculated with KHFV cl-5, but not
mice inoculated with KHFV cl-4, contain hemorrhagic
lesions in the renal medulla. Then we conducted patho-
logical examination of the kidneys of mice inoculated
with KHFV cl-5.
Pathological changes in kidneys
Mice were inoculated with 105 FFU of KHFV cl-5 via
the i.v. route, and kidneys were collected from three
mice each at 3, 6, 9 and 12 dpi and subjected to patho-
logical examination. There was no pathological change
at 3 dpi. However, after 6 dpi, macroscopic hemorrhagic
lesions began to be observed in the renal medulla of
KHFV cl-5-infected mice (Figs. 2 and 3). The severity of
hemorrhage peaked at 9 dpi and was weakened at 12
dpi. Histopathological examination showed that conges-
tion and hemorrhage were prominent in the border
between the renal cortex and medulla (Fig. 4). A
flattened tubular epithelium, dilated lumina and infiltrat-
ing cells were observed in the renal medulla (Fig. 4). These
pathological changes after 6 dpi were observed in all of
the infected mice.
Dose-dependency of the pathogenicity in mice
To determine whether KHFV cl-5 causes disease in
mice in a dose-dependent manner, serial 10-fold dilu-
tions of the virus (105 to 102 FFU) were inoculated
into each of 7 mice via the i.v. route and the mice
were observed for 2 weeks. All of the mice inoculated
with 105 FFU and 104 FFU of KHFV cl-5 developed
signs of disease, while none of the mice inoculated
with 103 and 102 FFU of the virus showed signs of
disease (Table 2). The dose causing disease in 50% of mice
was calculated to be 3.2 × 103 FFU by the method of Reed
and Muench [13].
Specificity of virus in disease development
To confirm that the disease was caused by KHFV infec-
tion and not by unknown etiology, 105 FFU of KHFV
Table 1 Morbidity in mice infected with KHFV cl-1 to -5
Virusa Route of infection
i.p. i.v.
KHFV cl-1 0/2b 3/3
KHFV cl-2 0/2 3/3
KHFV cl-3 0/3 3/3
KHFV cl-4 0/3 0/3
KHFV cl-5 1/3 3/3
a105 FFU/mouse
bNumber of mice showing transient weight loss and ruffled fur/Number of
mice inoculated
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cl-5 was pretreated with a neutralizing antibody to
HTNV strain 76-118, which is the same serotype as
KHFVs, or with normal mouse serum for 1 h at 37 °C and
then inoculated into mice via the i.v. route. The mice
inoculated with the virus pretreated with normal
mouse serum showed transient body weight loss
around 6 to 9 dpi. In contrast, the mice inoculated
with the virus pretreated with the neutralizing anti-
body developed no signs of disease (Fig. 5). Patho-
logical examination showed that renal hemorrhage
occurred at 10 dpi in mice inoculated with the virus
pretreated with normal mouse serum but did not
occur in mice inoculated with the virus pretreated
with the neutralizing antibody. These results indicate
that the disease development was caused by KHFV
infection.
Comparison of viral genome sequences of KHFV cl-4 and cl-5
To reveal the differences in genetic background be-
tween KHFV cl-4 and cl-5, which showed different
virulency, genome sequences were determined and
compared. In the ORF of the N gene, there was no
difference between KHFV cl-4 and cl-5. In the ORF
of the GP gene, the nucleotide at position 1249 was
different, causing an amino acid difference at position
417 in the glycoprotein Gn: lysine for KHFV cl-4 and
glutamic acid for KHFV cl-5 (Table 3). In the ORF of
RdRp gene, the nucleotide at position 6363 was dif-
ferent, but it did not cause an amino acid difference.
The results indicate that the amino acid at position
417 in the glycoprotein Gn is the sole amino acid dif-
ference in viral proteins between KHFV cl-4 and cl-5.
The amino acids at position 417 in Gn of KHFV cl-1,
−2 and −3 were the same as that in Gn of KHFV cl-
5. In the non-coding regions of S, M and L segments,
there was no difference between KHFV cl-4 and cl-5.
Fig. 1 Changes in body weight of KHFV-infected mice. Mice were intravenously inoculated with 105 FFU of KHFV cl-1 to -5 and observed for
2 weeks. Body weight of mice at the time of inoculation was set as baseline, and percent changes from the baseline are shown. The values are
averages and standard deviations of percent changes
Fig. 2 Quantities of viral RNA in kidneys of KHFV-infected mice. Mice
were intravenously inoculated with 105 FFU of KHFV cl-4 and cl-5.
Quantities of viral RNA in kidneys of mice at 3, 6, 9 and 12 days post-
inoculation were determined by real-time PCR. The values are averages
and standard deviations of the copy number of viral RNA. Asterisks
indicate a significant difference in quantity of viral RNA (P < 0.05)
Fig. 3 Images of kidneys of KHFV cl-5-infected mice at 9 days post-
inoculation. Kidneys of mice intravenously inoculated with 105 FFU
of KHFV cl-5 were subjected to pathological examination. There were
three mice per group. Representative images are shown
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Discussion
In this study, we found KHFV clones causing renal
hemorrhage in adult BALB/c mice after inoculation via
the i.v. route. The development of disease was inhibited
by pretreatment of an inoculum with a neutralizing anti-
body against HTNV strain 76-118, which is the same
serotype as KHFV clones, indicating that the disease was
caused by KHFV infection. Renal hemorrhagic lesions in
the mice were macroscopically limited to the medullary
region, which is one of the characteristic pathological
changes in severe HFRS patients [14]. Widespread capil-
lary engorgement, interstitial hemorrhage, flattened
tubular epithelium, dilated lumina and infiltrating cells
in the renal medullary region in the mice have also been
observed in HFRS patients [15, 16]. These results indi-
cate that the pathological lesion that developed in the
kidney of KHFV-infected mice was similar to that in
HFRS patients.
Immune responses are thought to be related to the
pathogenesis of hantavirus infection. In HFRS patients,
increased numbers of CD8+ T cells and a decrease in
the ratio of CD4+ T cells to CD8+ T cells have been re-
ported [17]. In HPS patients, high levels of T cells and
cytokine-producing cells were found in lungs [18], and T
cell numbers have been suggested to correlate with dis-
ease severity [19]. In our mouse model, cells infiltrating
the renal medulla were observed in the KHFV-infected
mice. Importance of viral propagation in disease severity
has also been reported. Yi et al. [20] reported that HFRS
patients in a severe group had higher viral loads in the
early stage of disease than did those in a mild/moderate
group. We also showed that the quantity of viral RNA in
kidneys of KHFV cl-5-infected mice was larger than
those of KHFV cl-4-infected mice and peaked before the
onset of disease. The initial virus propagation may ex-
cessively induce host immunity and cause disease after-
ward. Alternatively, there is a possibility that damage
caused by the initial virus propagation was sufficient to
ultimately result in disease development despite onset of
virus clearance by the immune response. It would be in-
teresting to examine the number of T cells in the kidney
and the role of T cells in the pathogenesis in KHFV-





Fig. 4 Histopathological images of the kidneys of KHFV cl-5-infected mice at 9 days post-inoculation. Kidneys of mice intravenously inoculated
with 105 FFU of KHFV cl-5 were subjected to histopathological examination. There were three mice per group. Representative images are shown
Table 2 Morbidity in mice intravenously inoculated with different






aNumber of mice showing transient weight loss and ruffled fur/number of
mice inoculated
Fig. 5 Changes in body weight of mice inoculated with neutralizing
antibody-treated KHFV cl-5. The inoculum of KHFV cl-5 (105 FFU) was
pretreated with a neutralizing antibody against HTNV strain 76-118
or with normal mouse serum at 37 °C for 1 h. Body weight of mice
at the time of inoculation was set as baseline, and percent changes
from the baseline are shown. The values are averages and standard
deviations of percent changes
Shimizu et al. Virology Journal  (2017) 14:13 Page 5 of 7
Although Asada et al. [10] reported that KHFV killed
adult mice after intravenous inoculation, we could not
reproduce the lethal outcome by using KHFV clones for
unknown reasons. However, KHFV clones caused renal
hemorrhage in adult mice. Because of the unavailability
of the same virus and mice as those used by Asada et al.,
we could not examine the reason for the different
outcomes. Instability of character of hantavirus has been
reported in previous studies. Wichmann et al. [9] re-
ported that HTNV strain 76-118 caused lethal neuro-
logical disease in adult laboratory mice. However, the
result could not be reproduced in other laboratories.
Klingstrom et al. [21] reported that mice inoculated with
cell culture-passaged PUUV showed lower IgG produc-
tion compared to wild-type PUUV. Safronetz et al. [3]
reported that deer mouse-only-passaged SNV, but not
Vero cell-passaged SNV, caused severe respiratory dis-
ease in rhesus macaques. Therefore, there is a possibility
that characters of KHFV clones are changed by passages
in some tissues and cells. Although we confirmed that
the phenotype of KHFV cl-5 was maintained after three
times of passages in Vero E6 cells, it will be important
to prepare virus stock with lower number of passages
and to confirm the character of the virus stock after
preparation.
We found that KHFV cl-4 did not cause disease in
mice and that the amino acid at position 417 in the
glycoprotein Gn is the sole amino acid difference in viral
proteins between KHFV cl-4 and cl-5. The amino acid at
position 417 in Gn of KHFV cl-1 to -3 was the same as
that of KHFV cl-5. These results suggest that the amino
acid at position 417 in Gn is involved in the difference
in pathogenicity between KHFV cl-4 and cl-5. However,
analysis of database showed that almost all of the HTNV
strains have an amino acid shared by virulent clones, al-
though HTNV strains generally cause no disease in adult
mice. Therefore, other factors should be involved in the
difference of pathogenicity between KHFV cl-5 and
other HTNV strains. Because the amino acid at position
417 was located in the ectodomain of Gn, the amino
acid difference may affect the function of Gn such as
binding to and entry into host cells. In fact, the quantity
of viral RNAs in kidneys of KHFV cl-4-infected mice
was smaller than that in KHFV cl-5-infected mice at any
time point. The difference in viral propagation between
KHFV cl-4 and cl-5 may lead to the difference in patho-
genicity. Further studies are needed to elucidate the
mechanism by which the amino acid at position 417 is
involved in the pathogenesis.
Conclusions
We found KHFV clones causing renal hemorrhage in
adult mice, which is similar to that in HFRS patients.
Closely related viral clones with different pathogenicities
were obtained. In addition, a single amino acid differ-
ence in viral proteins between high-pathogenic and
low-pathogenic clones was identified. Although it is ne-
cessary to examine whether the mouse model shares
some mechanisms of the pathogenesis in humans, we
anticipate that this infection model will improve the
understanding of HFRS pathogenesis.
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Table 3 Differences in sequences of viral genes between KHFV
cl-4 and −5








KHFV cl-4 –c – A Lys G –
KHFV cl-5 – – G Glu A –
aNucleotide sequence
bDeduced amino acid sequence
cNo Difference
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